Arbor Rapha Capital Bioholdings Corp I (ARCK)
$11.90
$0.00 (0.00%)As on 10-Mar-2023 09:30EDT
Market cap
$257 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
0 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0
-
Debt to Equity
-0.5
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
17,250,000
8 Years Aggregate
CFO
$-0.54 Mln
EBITDA
$--
Net Profit
$-1.47 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Arbor Rapha Capital Bioholdings Corp I (ARCK)
| 9.7 | 0.0 | 16.0 | 18.9 | -- | 53.9 | 11.1 |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Arbor Rapha Capital Bioholdings Corp I (ARCK)
|
11.9 | 256.6 | 0.0 | -445,615.7 | -- | -- | -- | 0.0 |
| 3.9 | 90.0 | 6.3 | -24.8 | 0.0 | -239.2 | -- | 9.0 | |
| 9.5 | 451.0 | 330.4 | 100.2 | 43.3 | 30.4 | 4.7 | 1.3 | |
| 47.1 | 17,492.4 | 3,962.7 | 363.9 | 19.1 | 4.2 | 51.1 | 3.3 | |
| 13.4 | 778.1 | 0.0 | -134.2 | -- | -40.2 | -- | 0.0 | |
| 17.8 | 5,305.3 | 440.3 | -1,435.0 | -318.6 | -- | -- | 0.0 | |
| 0.8 | 88.4 | 16.5 | -34.9 | -207.0 | -89.6 | -- | 2.4 | |
| 11.1 | 3,347.6 | 2,882.5 | -118.3 | 4.1 | -- | -- | 1.4 | |
| 42.8 | 24,138.9 | 2,645.8 | 12.6 | 0.6 | -4.9 | 996.9 | 7.5 | |
| 11.6 | 381.6 | 57.6 | -50.7 | -85.0 | -54.9 | -- | 2.8 |
Shareholding Pattern
View DetailsAbout Arbor Rapha Capital Bioholdings Corp I (ARCK)
Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more... businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York. Read more
-
Chairman, CEO & Pres
Mr. Ivan Paul Kaufman
-
Chairman, CEO & Pres
Mr. Ivan Paul Kaufman
-
Headquarters
Uniondale, NY
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Arbor Rapha Capital Bioholdings Corp I (ARCK)
What is the current share price of Arbor Rapha Capital Bioholdings Corp I (ARCK) Today?
The share price of Arbor Rapha Capital Bioholdings Corp I (ARCK) is $11.90 (NASDAQ) as of 10-Mar-2023 09:30 EDT. Arbor Rapha Capital Bioholdings Corp I (ARCK) has given a return of 18.88% in the last 1 years.
What is the current PB & PE ratio of Arbor Rapha Capital Bioholdings Corp I (ARCK)?
Since, TTM earnings of Arbor Rapha Capital Bioholdings Corp I (ARCK) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
2016 |
-- |
-- |
2015 |
-- |
-- |
What is the 52 Week High and Low of Arbor Rapha Capital Bioholdings Corp I (ARCK)?
The 52-week high and low of Arbor Rapha Capital Bioholdings Corp I (ARCK) are Rs -- and Rs -- as of 05-Sep-2026.
What is the market cap of Arbor Rapha Capital Bioholdings Corp I (ARCK)?
Arbor Rapha Capital Bioholdings Corp I (ARCK) has a market capitalisation of $ 257 Mln as on 10-Mar-2023. As per SEBI classification, it is a company.
Should I invest in Arbor Rapha Capital Bioholdings Corp I (ARCK)?
Before investing in Arbor Rapha Capital Bioholdings Corp I (ARCK), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.